BIOAF (Bioasis Technologies) Net Margin % : -660.36% (As of Nov. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Bioasis Technologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Bioasis Technologies's Net Income for the three months ended in Nov. 2022 was $-0.73 Mil. Bioasis Technologies's Revenue for the three months ended in Nov. 2022 was $0.11 Mil. Therefore, Bioasis Technologies's net margin for the quarter that ended in Nov. 2022 was -660.36%.

The historical rank and industry rank for Bioasis Technologies's Net Margin % or its related term are showing as below:

BIOAF's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -110.23
* Ranked among companies with meaningful Net Margin % only.

Bioasis Technologies Net Margin % Historical Data

The historical data trend for Bioasis Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Net Margin % Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Net Margin %

Get a 7-Day Free Trial

-899.15

-244.10

-669.52

17.12

-7,763.33

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Net Margin %	Get a 7-Day Free Trial															-3,373.33	-	-	-907.53	-660.36

Competitive Comparison of Bioasis Technologies's Net Margin %

For the Biotechnology subindustry, Bioasis Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Net Margin % falls into.

Save Embed

;

Save Embed

;

Bioasis Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bioasis Technologies's Net Margin for the fiscal year that ended in Feb. 2022 is calculated as

Net Margin	=	Net Income (A: Feb. 2022 )	/	Revenue (A: Feb. 2022 )
	=	-2.329	/	0.03
	=	-7,763.33 %

Bioasis Technologies's Net Margin for the quarter that ended in Nov. 2022 is calculated as

Net Margin	=	Net Income (Q: Nov. 2022 )	/	Revenue (Q: Nov. 2022 )
	=	-0.733	/	0.111
	=	-660.36 %

Bioasis Technologies (OTCPK:BIOAF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Bioasis Technologies Net Margin % Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (OTCPK:BIOAF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.